Covered recipient · General Payments record
DENNIS J WIWI
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2019
$613.60
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $339.99 | 13 |
| Education | $28.17 | 2 |
| Gift | $16.50 | 1 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $162.52 | 5 |
| Minerva Surgical, Inc | $91.36 | 2 |
| AMAG Pharmaceuticals, Inc. | $28.17 | 2 |
| TherapeuticsMD, Inc. | $26.12 | 2 |
| Merck Sharp & Dohme Corporation | $25.52 | 2 |
| Roche Diagnostics Corporation | $17.35 | 1 |
| Lupin Inc. | $17.12 | 1 |
| ASCEND THERAPEUTICS US, LLC | $16.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie, Inc. | $113.02 | 01/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | 647947941 | CMS |
| AbbVie, Inc. | $16.52 | 02/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | 647947949 | CMS |
| AbbVie, Inc. | $9.26 | 05/02/2019 | Food and Beverage | Undisputed | 01/23/2026 | 647947969 | CMS |
| AbbVie, Inc. | $10.48 | 10/17/2019 | Food and Beverage | Undisputed | 01/23/2026 | 647947987 | CMS |
| AbbVie, Inc. | $13.24 | 12/17/2019 | Food and Beverage | Undisputed | 01/23/2026 | 647947997 | CMS |
| AMAG Pharmaceuticals, Inc. | $12.70 | 04/30/2019 | Education | Undisputed | 01/23/2026 | 698543865 | CMS |
| AMAG Pharmaceuticals, Inc. | $15.47 | 12/10/2019 | Education | Undisputed | 01/23/2026 | 698543867 | CMS |
| ASCEND Therapeutics US, LLC | $16.50 | 03/18/2019 | Gift | Undisputed | 01/23/2026 | 688647405 | CMS |
| Lupin Inc. | $17.12 | 10/28/2019 | Food and Beverage | Undisputed | 01/23/2026 | 704134611 | CMS |
| Merck Sharp & Dohme Corporation | $12.65 | 05/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | 695470735 | CMS |
| Merck Sharp & Dohme Corporation | $12.87 | 11/25/2019 | Food and Beverage | Undisputed | 01/23/2026 | 695834079 | CMS |
| Minerva Surgical, Inc | $19.51 | 04/02/2019 | Food and Beverage | Undisputed | 01/23/2026 | 705659767 | CMS |
| Minerva Surgical, Inc | $71.85 | 05/30/2019 | Food and Beverage | Undisputed | 01/23/2026 | 705659769 | CMS |
| Roche Diagnostics Corporation | $17.35 | 08/29/2019 | Food and Beverage | Undisputed | 01/23/2026 | 671024199 | CMS |
| TherapeuticsMD, Inc. | $12.30 | 01/22/2019 | Food and Beverage | Undisputed | 01/23/2026 | 703087067 | CMS |
| TherapeuticsMD, Inc. | $13.82 | 07/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | 703087069 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.